Primary Site >> Colorectal Cancer

Gene >> PGF

Journal: Cancer Res. 1999 Aug 15;59(16):4129-35.
Title: Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.
Author: Monsky, W L|Fukumura, D|Gohongi, T|Ancukiewcz, M|Weich, H A|Torchilin, V P|Yuan, F|Jain, R K
PMID: 10463618
Journal: Cancer Res. 2003 Apr 15;63(8):1748-51.
Title: Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells.
Author: Cutler, N Shane|Graves-Deal, Ramona|LaFleur, Bonnie J|Gao, Zhenqiang|Boman, Bruce M|Whitehead, Robert H|Terry, Erin|Morrow, Jason D|Coffey, Robert J
PMID: 12702555
Journal:
Title: (64)Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-quantum dot-vascular endothelial growth factor
Author: Zhang, Huiming
PMID: 20641777
Journal: Gut. 2005 May;54(5):666-72.
Title: Placenta growth factor expression is correlated with survival of patients with colorectal cancer.
Author: Wei, S-C|Tsao, P-N|Yu, S-C|Shun, C-T|Tsai-Wu, J-J|Wu, C H H|Su, Y-N|Hsieh, F-J|Wong, J-M
PMID: 15831913
Journal: Int J Cancer. 2006 Feb 1;118(3):755-64.
Title: Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy.
Author: Zaman, Khalil|Driscoll, Robert|Hahn, Diane|Werffeli, Patricia|Goodman, Simon L|Bauer, Jean|Leyvraz, Serge|Lejeune, Ferdy|Stupp, Roger|Ruegg, Curzio
PMID: 16114015
Journal: World J Gastroenterol. 2006 Jan 7;12(1):60-5.
Title: Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells.
Author: Kurata, Masanao|Okajima, Kenji|Kawamoto, Toru|Uchiba, Mitsuhiro|Ohkohchi, Nobuhiro
PMID: 16440418
Journal: Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2274-9.
Title: New marker of colon cancer risk associated with heme intake: 1,4-dihydroxynonane mercapturic acid.
Author: Pierre, Fabrice|Peiro, Geraldine|Tache, Sylviane|Cross, Amanda J|Bingham, Sheila A|Gasc, Nicole|Gottardi, Gaelle|Corpet, Denis E|Gueraud, Francoise
PMID: 17119057
Journal: Cancer Res. 2007 Feb 1;67(3):881-9.
Title: Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice.
Author: Park, Jae Man|Kanaoka, Yoshihide|Eguchi, Naomi|Aritake, Kosuke|Grujic, Sava|Materi, Alicia M|Buslon, Virgilio S|Tippin, Brigette L|Kwong, Alan M|Salido, Eduardo|French, Samuel W|Urade, Yoshihiro|Lin, Henry J
PMID: 17283118
Journal: Int J Cancer. 2007 Aug 15;121(4):734-40.
Title: Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells.
Author: Qualtrough, David|Kaidi, Abderrahmane|Chell, Simon|Jabbour, Henry N|Williams, Ann C|Paraskeva, Christos
PMID: 17437271
Journal: Mol Cancer Res. 2007 Sep;5(9):873-80.
Title: Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma.
Author: Xu, Lei|Jain, Rakesh K
PMID: 17704140
Journal: Pharm Res. 2008 Jul;25(7):1552-62.
Title: Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
Author: He, Xuezhong|Ma, Junyu|Mercado, Angel E|Xu, Weijie|Jabbari, Esmaiel
PMID: 18196205
Journal: Prostaglandins Other Lipid Mediat. 2009 Nov;90(1-2):31-6.
Title: Inhibition of prostaglandin E(2) signaling through the EP(1) receptor does not affect prostacyclin production in human endothelial cells.
Author: Kaneshiro, Tatsuya|Okumura, Masae|Maalouf, Samer|Uflacker, Andre|Maruyama, Takayuki|Kawamori, Toshihiko
PMID: 19647091
Journal: Br J Pharmacol. 2009 Dec;158(7):1771-6.
Title: Cyclic AMP-mediated chloride secretion is induced by prostaglandin F2alpha in human isolated colon.
Author: Collins, D|Hogan, A M|Skelly, M M|Baird, A W|Winter, D C
PMID: 19889058
Journal: Cancer Res. 2009 Oct 15;69(20):7905-10.
Title: Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.
Author: Xu, Lei|Duda, Dan G|di Tomaso, Emmanuelle|Ancukiewicz, Marek|Chung, Daniel C|Lauwers, Gregory Y|Samuel, Rekha|Shellito, Paul|Czito, Brian G|Lin, Pei-Chun|Poleski, Martin|Bentley, Rex|Clark, Jeffrey W|Willett, Christopher G|Jain, Rakesh K
PMID: 19826039
Journal: Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):239-46.
Title: PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance.
Author: Escudero-Esparza, Astrid|Martin, Tracey A|Davies, Mansel Leigh|Jiang, Wen G
PMID: 19657001
Journal: J Clin Oncol. 2009 Jun 20;27(18):3020-6.
Title: Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.
Author: Willett, Christopher G|Duda, Dan G|di Tomaso, Emmanuelle|Boucher, Yves|Ancukiewicz, Marek|Sahani, Dushyant V|Lahdenranta, Johanna|Chung, Daniel C|Fischman, Alan J|Lauwers, Gregory Y|Shellito, Paul|Czito, Brian G|Wong, Terence Z|Paulson, Erik|Poleski, Mart
PMID: 19470921
Journal: Biomed Pharmacother. 2009 Aug;63(7):522-7.
Title: Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F(2)alpha.
Author: Tsai, Chin-Shaw Stella|Luo, Shue-Fen|Ning, Chung-Chu|Lin, Chien-Liang|Jiang, Ming-Chung|Liao, Ching-Fong
PMID: 18849138
Journal: Oncologist. 2010;15(6):577-83.
Title: Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.
Author: Duda, Dan G|Willett, Christopher G|Ancukiewicz, Marek|di Tomaso, Emmanuelle|Shah, Mira|Czito, Brian G|Bentley, Rex|Poleski, Martin|Lauwers, Gregory Y|Carroll, Madeline|Tyler, Douglas|Mantyh, Christopher|Shellito, Paul|Clark, Jeffrey W|Jain, Rakesh K
PMID: 20484123
Journal: Surg Endosc. 2011 Jul;25(7):2153-8.
Title: Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection.
Author: Shantha Kumara, H M C|Cabot, Jenny C|Yan, Xiaohong|Herath, Sonali A C|Luchtefeld, Martin|Kalady, Matthew F|Feingold, Daniel L|Baxter, Raymond|Whelan, Richard L
PMID: 21184108
Journal: Mol Cancer Ther. 2011 Mar;10(3):404-15.
Title: sFLT01: a novel fusion protein with antiangiogenic activity.
Author: Bagley, Rebecca G|Kurtzberg, Leslie|Weber, William|Nguyen, Tri-Hung|Roth, Stephanie|Krumbholz, Roy|Yao, Min|Richards, Brenda|Zhang, Mindy|Pechan, Peter|Schmid, Steve|Scaria, Abraham|Kaplan, Johanne|Teicher, Beverly A
PMID: 21252283
Journal: Rapid Commun Mass Spectrom. 2011 Mar 30;25(6):755-64.
Title: Ultra-pressure liquid chromatography/tandem mass spectrometry targeted profiling of arachidonic acid and eicosanoids in human colorectal cancer.
Author: Mal, Mainak|Koh, Poh Koon|Cheah, Peh Yean|Chan, Eric Chun Yong
PMID: 21337637
Journal: Br J Cancer. 2011 Apr 12;104(8):1270-7.
Title: Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration.
Author: Fan, F|Samuel, S|Gaur, P|Lu, J|Dallas, N A|Xia, L|Bose, D|Ramachandran, V|Ellis, L M
PMID: 21407219
Journal: J Biol Chem. 2011 Jun 3;286(22):19641-51.
Title: The biflavonoid amentoflavone inhibits neovascularization preventing the activity of proangiogenic vascular endothelial growth factors.
Author: Tarallo, Valeria|Lepore, Laura|Marcellini, Marcella|Dal Piaz, Fabrizio|Tudisco, Laura|Ponticelli, Salvatore|Lund, Frederik Wendelboe|Roepstorff, Peter|Orlandi, Augusto|Pisano, Claudio|De Tommasi, Nunziatina|De Falco, Sandro
PMID: 21471210
Journal: Hepatogastroenterology. 2012 Jul-Aug;59(117):1437-40.
Title: Is serum placental growth factor a prognostic marker for stage III colorectal cancer patients?
Author: Gomceli, Ismail|Tez, Mesut|Bostanci, Erdal B|Ulas, Murat|Turhan, Nesrin|Kemik, Ahu S|Akoglu, Musa
PMID: 22155858
Journal: J Korean Soc Coloproctol. 2012 Dec;28(6):315-20.
Title: Expression of placenta growth factor in colorectal carcinomas.
Author: Sung, Chan Yong|Son, Myoung Won|Ahn, Tae Sung|Jung, Dong Jun|Lee, Moon Soo|Baek, Moo Jun
PMID: 23346511
Journal: BMC Cancer. 2012 Nov 13;12:515.
Title: Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members.
Author: Pringels, Sarah|Van Damme, Nancy|De Craene, Bram|Pattyn, Piet|Ceelen, Wim|Peeters, Marc|Grooten, Johan
PMID: 23148666
Journal: PLoS One. 2012;7(6):e38231.
Title: Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.
Author: Meyerhardt, Jeffrey A|Ancukiewicz, Marek|Abrams, Thomas A|Schrag, Deborah|Enzinger, Peter C|Chan, Jennifer A|Kulke, Matthew H|Wolpin, Brian M|Goldstein, Michael|Blaszkowsky, Lawrence|Zhu, Andrew X|Elliott, Meaghan|Regan, Eileen|Jain, Rakesh K|Duda, Dan G
PMID: 22701615
Journal: World J Gastroenterol. 2012 Feb 21;18(7):637-45.
Title: Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
Author: Abajo, Ana|Bitarte, Nerea|Zarate, Ruth|Boni, Valentina|Lopez, Ines|Gonzalez-Huarriz, Marisol|Rodriguez, Javier|Bandres, Eva|Garcia-Foncillas, Jesus
PMID: 22363134
Journal: J Cell Physiol. 2012 Aug;227(8):3128-37.
Title: The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells.
Author: Chien, Chih-Chiang|Ko, Ching-Huai|Shen, Shing-Chuan|Yang, Liang-Yo|Chen, Yen-Chou
PMID: 22170686
Journal: Can J Aging. 2012 Jun;31(2):161-71.
Title: Exercise training reduces inflammatory mediators in the intestinal tract of healthy older adult mice.
Author: Packer, Nicholas|Hoffman-Goetz, Laurie
PMID: 22647663
Journal: Clin Colorectal Cancer. 2013 Jun;12(2):86-94.
Title: Adverse events associated with antiangiogenic agents in combination with cytotoxic chemotherapy in metastatic colorectal cancer and their management.
Author: Cartwright, Thomas H
PMID: 23562587
Journal: BMC Cancer. 2013 May 7;13:229.
Title: Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells.
Author: Yamagishi, Naoko|Teshima-Kondo, Shigetada|Masuda, Kiyoshi|Nishida, Kensei|Kuwano, Yuki|Dang, Duyen T|Dang, Long H|Nikawa, Takeshi|Rokutan, Kazuhito
PMID: 23651517
Journal: J Gastrointest Oncol. 2013 Jun;4(2):231-8.
Title: Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib.
Author: Jitawatanarat, Potjana|Wee, Wen
PMID: 23730520
Journal: J Biomed Sci. 2013 Jun 21;20:39.
Title: Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway.
Author: Wei, Shu-Chen|Tsao, Po-Nien|Weng, Meng-Tzu|Cao, Zhifang|Wong, Jau-Min
PMID: 23799978
Journal: Oncol Rep. 2014 Dec;32(6):2493-500.
Title: Upregulation of stromal cell-derived factor 1alpha expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: angiogenic markers of neoadjuvant chemoradiation.
Author: Kim, Han Jo|Bae, Sang Byung|Jeong, Dongjun|Kim, Eun Seog|Kim, Chang-Nam|Park, Dong-Guk|Ahn, Tae Sung|Cho, Sung Woo|Shin, Eung Jin|Lee, Moon Soo|Baek, Moo Jun
PMID: 25241658
Journal: Gastroenterol Res Pract. 2014;2014:526178.
Title: Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept.
Author: Giordano, Guido|Febbraro, Antonio|Venditti, Michele|Campidoglio, Serena|Olivieri, Nunzio|Raieta, Katia|Parcesepe, Pietro|Imbriani, Giusy Carmen|Remo, Andrea|Pancione, Massimo
PMID: 25136356
Journal: Oncotarget. 2014 May 15;5(9):2588-95.
Title: Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma.
Author: Hayashi, Hidetoshi|Arao, Tokuzo|Matsumoto, Kazuko|Kimura, Hideharu|Togashi, Yosuke|Hirashima, Yoshinori|Horita, Yosuke|Iwasa, Satoru|Okita, Natsuko Tsuda|Honma, Yoshitaka|Takashima, Atsuo|Kato, Ken|Hamaguchi, Tetsuya|Shimada, Yasuhiro|Nakagawa, Kazuhiko|N
PMID: 24809949
Journal: Mol Cancer Ther. 2014 Jun;13(6):1636-44.
Title: Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancer.
Author: Chiron, Marielle|Bagley, Rebecca G|Pollard, Jack|Mankoo, Parminder K|Henry, Christophe|Vincent, Loic|Geslin, Catherine|Baltes, Nina|Bergstrom, Donald A
PMID: 24688047
Journal: J Med Invest. 2015;62(1-2):75-9.
Title: Chronic exposure of VEGF inhibitors promotes the malignant phenotype of colorectal cancer cells.
Author: Tomida, Chisato|Yamagishi, Naoko|Aibara, Kana|Yano, Chiaki|Uchida, Takayuki|Abe, Tomoki|Ohno, Ayako|Hirasaka, Katsuya|Nikawa, Takeshi|Teshima-Kondo, Shigetada
PMID: 25817288
Journal: BMC Cancer. 2015 Mar 7;15:104.
Title: Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.
Author: Jayasinghe, Caren|Simiantonaki, Nektaria|Kirkpatrick, Charles James
PMID: 25880726
Journal: Tumour Biol. 2015 Sep;36(10):7399-407.
Title: Efficient inhibition of growth of metastatic cancer cells after resection of primary colorectal cancer by soluble Flt-1.
Author: Zhang, Yong|Li, Ao|Peng, Weizhen|Sun, Jue|Xu, Fangming|Xu, Jianhua
PMID: 25895458
Journal: Sci Rep. 2016 Apr 22;6:24853.
Title: Soluble VEGF receptor 1 (sFLT1) induces non-apoptotic death in ovarian and colorectal cancer cells.
Author: Miyake, Tatsuya|Kumasawa, Keiichi|Sato, Noriko|Takiuchi, Tsuyoshi|Nakamura, Hitomi|Kimura, Tadashi
PMID: 27103202
Journal: Target Oncol. 2016 Aug;11(4):489-500.
Title: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC).
Author: Scartozzi, Mario|Vincent, Loic|Chiron, Marielle|Cascinu, Stefano
PMID: 27412031
Journal: Oncotarget. 2016 Nov 22;7(47):76613-76627.
Title: Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.
Author: Kleibeuker, Esther A|Fokas, Emmanouil|Allen, Philip D|Kersemans, Veerle|Griffioen, Arjan W|Beech, John|Im, Jaehong H|Smart, Sean C|Castricum, Kitty C|van den Berg, Jaap|Schulkens, Iris A|Hill, Sally A|Harris, Adrian L|Slotman, Ben J|Verheul, Henk M|Musche
PMID: 27780936
Journal: Cancer Chemother Pharmacol. 2017 Apr;79(4):661-671.
Title: An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism.
Author: Wang, Ka|Stark, Franziska Schaedeli|Schlothauer, Tilman|Lahr, Angelika|Cosson, Valerie|Zhi, Jianguo|Habben, Kai|Tessier, Jean|Schick, Eginhard|Staack, Roland F|Krieter, Oliver
PMID: 28314990
Journal: Invest New Drugs. 2017 Dec;35(6):782-790.
Title: Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.
Author: Lee, Su Jin|Lee, Seon Young|Lee, Weon Sup|Yoo, Jin San|Sun, Jong-Mu|Lee, Jeeyun|Park, Se Hoon|Park, Joon Oh|Ahn, Myung-Ju|Lim, Ho Yeong|Kang, Won Ki|Park, Young Suk
PMID: 28391576
Journal: J BUON. 2018 Jul-Aug;23(4):1149-1155.
Title: Analyzing the molecular mechanism of the tissue specificity of gastrointestinal stromal tumors by using bioinformatics approaches.
Author: Ma, Ning|Xu, Huaen|Zhou, Yun|Liu, MingYue|Wei Zhou, Jian|Jie Wang, Chao
PMID: 30358224